Search databaseBooksAll DatabasesAssemblyBiocollectionsBioProjectBioSampleBioSystemsBooksClinVarConserved DomainsdbGaPdbVarGeneGenomeGEO DataSetsGEO ProfilesGTRHomoloGeneIdentical Protein net CatalogNucleotideOMIMPMCPopSetProteinProtein ClustersProtein family members ModelsPubChem BioAssayPubChem CompoundPubChem SubstancePubMedSNPSRAStructureTaxonomyToolKitToolKitAllToolKitBookgh Bookshelf. A company of the national Library of Medicine, national Institutes of Health.

You are watching: Which affects osteoblast and osteoclast activity

StatPearls . Endowment Island (FL): StatPearls Publishing; 2021 Jan-.



Bones are not inert structures within the human being body; they continue to readjust over the course of a lifespan. This procedure of skeletal readjust is known as bone remodeling, i beg your pardon both protects the structural integrity of the skeleton system and metabolically contributes come the body"s balance that calcium and also phosphorus. Remodeling involves the resorption of old or damaged bone, followed by the deposition of new bone material. The German anatomist and also surgeon Julius Wolff occurred a regulation that defines the nature of bone remodeling about stresses. Wolff"s regulation states that bones will adapt to the degree of mechanically loading, such that boost in loading will cause the design of the internal, spongy bone to strengthen, complied with by the strengthening of the cortical layer. Furthermore, a decrease in tension on the bone will cause these bone layers to weaken. The duration, magnitude, and also rate that forces applied to the bone (in various other words, tendons pulling at their attachments), dictate the method in which the verity of the bone is altered. There are mainly 2 cell that are responsible for both the resorption and deposition phases the bone remodeling: osteoclasts and also osteoblasts; however, osteocytes have a duty in this procedure as well. The task of these cells, particularly the osteoclasts, room influenced straight or indirectly by hormone signals. This interaction in between bone remodeling cells and hormones create the chance for a multitude that pathophysiological consequences.<1><2>


The cell of Bone Remodeling: The significant Players

The bone remodeling cycle, which begins in beforehand fetal life, depends on the interaction in between 2 cabinet lineages. Osteoblast cells contribute to bone growth and derive from the mesenchymal origin. Mesenchymal cells are stem cells that can differentiate into a range of cabinet types, such as osteoblasts, chondrocytes, myocytes, and adipocytes. Osteoclast cells reason bone resorption and also originate indigenous a hematopoietic lineage, which consists of various blood cell types from within the bone marrow. The cellular process of the remodeling starts when osteoblast and osteoclast precursor cells fuse to kind a multinucleated, osteoclastic cell.


Once the combination of osteoblast and also osteoclastic precursors has actually occurred, the result multinucleated osteoclast attaches come the bone surface and also commence resorption. This cells use a combination of lysosomal enzymes and hydrogen ions to malfunction the bone matrix. This bone procession is comprised of an inorganic part of calcium phosphate crystals (hydroxyapatite) and also an organic portion comprised the collagen, proteoglycans, and also glycoproteins. The resorption process leaves "scooped out" regions of the bone procession (Howship lacunae). Then it is thought that a "reversal" step is conducted by mononuclear cells of macrophage lineage continue to degrade and deposit organic material while release growth components to begin the bone deposition phase.


The distinguished mesenchymal precursors to fill the Howship Lacunae by depositing brand-new collagen and also minerals. As soon as the osteoblast has completed the task, it have the right to encounter three fates: flatten and become a cabinet to heat the bone surface, become an osteocyte, or experience cell death (apoptosis).


Osteocytes are the many abundant cell kind in mature bone. These cell types are situated within the bone matrix and occupy microscopic spaces referred to as lacuna. Castle play a duty in bone remodeling by transmitting signal to other surrounding osteocytes concerning bone stress and anxiety (tendons pulling top top the bone). Osteocytes are also involved in regulating fluid flow within the bone, for this reason this to move signal might be early out to alters in fluid flow in solution to mechanical stresses ~ above the bone. This cells are associated in the procedure called mechanotransduction, wherein the mechanical forces are converted to biochemical signals. Osteocytes act together conductors for this signal (or absence thereof), and they instruct bordering cells on how to compensate for and adapt come the mechanical stress.<3><4><5>


Hormonal impact on Bone Remodeling

Parathyroid Hormone (PTH)

PTH is a polypeptide hormone secreted by the chief cells of the parathyroid glands. That acts to raise the level of calcium in the bloodstream with direct actions on bone and also the kidneys and indirectly on the intestines via the affect on vitamin D. The hormone has actually a physiological, negative feedback loop affected by the amount of calcium current in the blood. Once there is a diminished plasma calcium concentration, over there is less binding to calcium-sensing receptors (CaSR) top top the parathyroid gland. This will bring about an increased release that PTH come raise the level of calcium. PTH has an indirect activity on the osteoclasts by enhancing the task of receptor activator of atom factor-kappa ligand (RANKL), i beg your pardon regulates the osteoclastic activity of bone resorption and leads to an ext calcium released right into the plasma. In contrast, high levels of plasma calcium tie to the CaSR on the parathyroid gland and also inhibit PTH release. Stimulating the CaSRs reasons a conformational adjust of the receptor and stimulates the phospholipase C pathway. This at some point leads to higher intracellular calcium, in order to inhibiting exocytosis of PTH from the chief cell of the parathyroid gland. This is, the course, just one piece to the calcium homeostasis puzzle due to the fact that PTH has actually actions at the kidneys and also intestines to manage the level of calcium and also phosphate.<6><7>


A deficiency the estrogen leads to raised bone remodeling, where bone resorption outpaces bone formation and decreases bone mass. Based on animal studies, the is thought that estrogen may affect local factors that control the precursors the osteoblasts and also osteoclasts. Estrogen might block the manufacturing and activity of interleukin-6 (IL-6), which would certainly hinder bone resorption. Also, the is believed that osteoclast survival thrives in the deficiency of estrogen, wherein the degree of bone turnover would certainly be greater.<8>


Calcitonin, a polypeptide hormone, is released from thyroid C cell in solution to elevated calcium levels. About bones, calcitonin binding to calcitonin receptors on osteoclasts come inhibit bone resorption. It is thought that calcitonin does no play a prominent function in calcium homeostasis in adults, yet it may be much more important in skeleton development. However, calcitonin is clinically used as a treatment choice to law osteoporosis.<9>

Growth Hormone

Growth Hormone (GH), a peptide hormone secreted through the pituitary gland, acts through insulin-like growth components to stimulate bone formation and also resorption. GH acts directly and also indirectly via IGF to wake up osteoblast proliferation and also activity, but it likewise stimulates osteoclastic bone resorption activity; however, the accumulation net effect of this double activity favors bone formation.


Glucocorticoids diminish bone formation by favoring the survival of osteoclasts and also causing the cell fatality of osteoblasts. There is an increase in RANKL activity and a to decrease in osteoprotegerin (OPG). OPG is a cytokine receptor and member of the organization necrosis variable superfamily that acts as a decoy receptor for RANKL, so that would usually hinder RANKL-RANK interaction and activity. 

Thyroid Hormone

Thyroid-stimulating hormone (TSH), thyroxine (T4), and also triiodothyronine (T3) cause bone elongation at the epiphyseal bowl of long bones with chondrocyte proliferation and likewise stimulate osteoblast activity. In claims of hypothyroidism or hyperthyroidism, the degree of bone sales is low and high, respectively. The rate of bone sales is as result of the effect of T3/T4 top top the number and activity level that osteoblasts and osteoclasts. Because that example, the high metabolic state the thyrotoxicosis causes increased osteoblast role and raised osteoclastic number and also activity, causing a higher bone turnover.<10>

Related Testing

Serum markers of Bone Formation

Evidence the bone development is shown by the visibility of alkaline phosphatase (ALP), bone alkaline phosphatase (B-ALP), osteocalcin (OC), and C- and also N-terminal propeptide of form 1 procollagen (PICP and PINP). ALP is certain for bone formation, yet only if the patient has no bile duct or liver disease. B-ALP is a specific product native osteoblast cells. OC is another particular osteoblast product, and there can be several active types. PICP and also PINP are products of proliferating fibroblasts and also osteoblasts.

Analytical Method

ALP = colorimetry, B-ALP = colorimetry, electrophoresis, immunoradiometric assay (IRMA), enzyme immunoassay (EIA), OC = radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), IRMA, electrochemiluminescence immunoassay (ECLIA), PICP and also PINP = RIA, ELISA

Serum mite of Bone Resorption

Bone resorption mite include, and are not minimal to, hydroxyproline (OHP), pyridinoline (PYD), deoxypyridinoline (DPD), bone sialoprotein (BSP), and tartrate-resistant mountain phosphatase (TR-ACP). OHP is a major part that protein collagen and plays a role in collagen stability. PYD has high concentration of bone collagen and also cartilage yet is not existing in the skin. Uneven PYD, DPD is highly concentrated in bone collagen yet is absent in cartilage and skin. BSP is make by osteoblasts and is present in the extracellular bone matrix. Osteoclasts, thrombocytes, and also erythrocytes do TR-ACP. 

Analytical Method

OHP = colorimetry, high performance liquid color layer analyzer (HPLC); PYD = HPLC, ELISA; DPD = HPLC, ELISA; BSP = RIA, ELISA; TR-ACP = colorimetry, RIA, ELISA.<11>

Imaging Techniques

Bone Scintigraphy: This scan uses nuclear medicine as a method of diagnosing various problems such as bone cancer (or metastasis), fractures, and infection/inflammation. The imaging an approach uses a gamma camera and requires one injection that technetium-99m-MDP to determine metabolically energetic regions the bone. This imaging method highlights sections of bones that have changes in bone turnover and perfusion.

Dual-energy X-ray Absorptiometry: Uses two X-ray beams of various energy level to identify the quantity of energy took in by bones (once soft organization absorption is subtracted). This technique is provided to monitor osteoporosis, where bone resorption task has out-paced bone mineralization.<12>


The following are conditions in which there is an imbalance between bone modeling and remodeling. The information presented here around these diseases is no extensive yet is intended to allude out the cellular imbalance that exists:


The most common metabolic disorder that the skeleton is osteoporosis, which is a diminish in bone mass that rises the hazard of bone fracture. The porous network of the trabecular bone in ~ the cortical bone is specifically weakened in osteoporosis, therefore bones that the wrist, hip, and spine possessing an ext trabecular bone are much more susceptible come fractures once exposed to adequate forces. A significant culprit the this disease is a diminish in estrogen. Postmenopausal women and estrogen-deficient men have actually an sped up bone turnover, where even though there is bone formation occurring, the is outpaced through the bone resorption the is taking place. The is thought that this may be due to osteoblast dysfunction or lose of design template bone from too much resorption. The is speculated that the to decrease in osteoblast role may be due to reduced synthesis or inhibition of local growth factors. Aging is additionally a risk element for osteoporosis, whereby there is a to decrease in the number of osteoblasts loved one to the demand for bone formation. Bone resorption outpaces bone formation as the human body ages.


This an illness process is consisted of of primary, secondary, and also tertiary causes. Major hyperparathyroidism have the right to be because of the breakthrough of one adenoma or hyperplasia the a parathyroid gland, which causes the production and also release of more PTH. The typical homeostatic system does not regulate the production and release of PTH indigenous a parathyroid adenoma. Therefore, it does not abide through feedback inhibition. Second hyperparathyroidism because of vitamin-D deficiency or chronic kidney disease is a state the hypocalcemia the leads come a secondary increase in PTH. Tertiary hyperparathyroidism outcomes from longstanding second hyperparathyroidism, wherein the parathyroid glands have hypertrophied over time and also overproduce PTH, which leads to hypercalcemia. As it involves bone remodeling, the mechanism of hyperparathyroidism was questioned in the prior "Mechanism" section.

Paget Disease

Paget an illness is a condition where osteoclasts have become abnormally activated and lead to a disorganized bone resorption pattern. Along with this distorted resorption come a strong, irregular osteoblastic an answer in the type of woven bone. Also though bone turnover is present, it leader to architecture with unfavorable integrity and can lead to pathologic fractures.


This is a condition that entails the fail of osteoclasts to resorb the bone matrix appropriately. Even though this results in raised bone mass, the bone verity is tho weak due to the fact that of the inability to resorb older sections of bone.<13>

Clinical Significance

The drugs used to reduce the effects of osteoporosis are particularly noteworthy for their clinical meaning on bone remodeling. The commonly used medications are provided below and also accompanied by their system of action. They space not provided in any specific order of any type of kind. They are presented right here for the sake of discussion around the affect they have on bone remodeling. This is no an exhaustive list.

Bisphosphonates (for example, alendronate): These medicines inhibit bone resorption by it is registered to hydroxyapatite binding sites, so once the osteoclast begins to resorb bone that has actually bisphosphonates attached to it, this impedes the osteoclast from arising the ruffled border. This influence the osteoclast"s ability to adhere come the bone surface and produce the protons required for this task. In addition to diminished osteoclastic activity, there shows up to be an osteoblastic survival benefit component as well.

Calcitonin: This medication inhibits bone resorption through inhibiting the activity of osteoclasts.

See more: Quest For The City Of Gold, (Treasure Hunters, 5) Hardcover

Raloxifene: Raloxifene is a selective estrogen receptor modulator (SERM), and also it has actually agonist task in bone and antagonist task in other tissues, together as breast tissue. The agonist activity in bone permits estrogenic impacts to occur. This way that it will certainly decrease the survival of osteoclasts and also hinder neighborhood bone resorption components such as IL-6. 

Denosumab: This is a person monoclonal antibody that binding RANKL. It decreases the activity and survive of osteoclasts by inhibiting the RANK-RANKL interaction, thereby limiting bone resorption.<14><15><16><17>

Lee JWY, Bance ML. Physiology that Osseointegration. Otolaryngol Clin phibìc Am. 2019 Apr;52(2):231-242.
Basurto-Acevedo L, Saucedo-García R, Vázquez-Martínez A, Cruz-García M, Valle-Hernández MM, Rosales-Cruz E, Sánchez-Arenas R. Relationship between bone remodeling and also metabolism in the elderly. Rev Med Inst Mex Seguro Soc. 2018;56(Suppl 1):S6-S11.
Anagnostis P, Gkekas NK, Potoupnis M, Kenanidis E, Tsiridis E, Goulis DG. New therapeutic targets for osteoporosis. Maturitas. 2019 Feb;120:1-6.
Lee BS. Myosins in Osteoclast Formation and also Function. Biomolecules. 2018 Nov 22;8(4)
Cosman F. Irreversible treatment tactics for postmenopausal osteoporosis. Curr Opin Rheumatol. 2018 Jul;30(4):420-426.
Bakr MM, Kelly WL, Brunt AR, Paterson BC, Massa HM, Morrison NA, Forwood MR. Solitary injection that PTH boosts osteoclastic parameters that remodeling at a stress fracture website in rats. J Orthop Res. 2019 May;37(5):1172-1182.
Rubin MR. Skeletal Manifestations of Hypoparathyroidism. Endocrinol Metab Clin north Am. 2018 Dec;47(4):825-837.
Gallagher JC. Developments in osteoporosis indigenous 1970 to 2018. Menopause. 2018 Dec;25(12):1403-1417.
Kenkre JS, Bassett J. The bone remodelling cycle. Ann Clin Biochem. 2018 May;55(3):308-327.
Wang L, Dong J, Xian CJ. Computational examination on the Biomechanical Responses of the Osteocytes come the Compressive Stimulus: A Poroelastic Model. Biomed Res Int. 2018;2018:4071356.
Garnero P. The utility of Biomarkers in Osteoporosis Management. Mol Diagn Ther. 2017 Aug;21(4):401-418.
Kucukalic-Selimovic E, Begic A. Worth of bone scintigraphy because that detection and also ageing the vertebral fractures in patient with serious osteoporosis and correlation between bone scintigraphy and mineral bone density. Med Arh. 2004;58(6):343-4.
Urano T, Shiraki M, Kuroda T, Tanaka S, Urano F, Uenishi K, Inoue S. Bisphosphonates prevent age-related weight loss in Japanese postmenopausal women. J Bone Miner Metab. 2018 Nov;36(6):734-740.
Li Y, Jin D, Xie W, Wen L, Chen W, Xu J, Ding J, Ren D, Xiao Z. Mesenchymal Stem Cells-Derived Exosomes: A possible Therapeutic Strategy because that Osteoporosis. Curr Stem cabinet Res Ther. 2018;13(5):362-368.
Wang T, Yu X, that C. Pro-inflammatory Cytokines: Cellular and Molecular medicine Targets because that Glucocorticoid-induced-osteoporosis via Osteocyte. Curr drug Targets. 2019;20(1):1-15.
Kanecki K, Nitsch-Osuch A, Goryński P, Bogdan M, Tarka P, Tyszko PZ. Paget disease of bone amongst hospitalized patient in Poland. Ann Agric Environ Med. 2018 Mar 14;25(1):182-185.
Elango J, Sanchez C, de Val JEMS, Henrotin Y, Wang S, Motaung KSCM, Guo R, Wang C, Robinson J, Regenstein JM, Bao B, Wu W. Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis ~ above collagen treatment. Sci Rep. 2018 Mar 28;8(1):5318.